To the Editor We read the article entitled, "Treatment with a Direct Oral Anticoagulant for Nonbacterial Thrombotic Endocarditis" by Tamura Y et al. in Internal Medicine Advance Publication 6368-20 (1) with great interest. The clinical team, including the authors, carefully assessed, treated, and described this extremely challenging case of nonbacterial thrombotic endocarditis (NBTE). The absence of changes on chest CT imaging for four years made it very difficult to make a correct diagnosis while she was alive. The authors obviously contributed to describing the pathogenesis of this rare disease: nonbacterial thrombotic endocarditis. However, three major questions should be addressed in relation to this patient's clinical course.As the US guidelines suggest, negative results from repeated blood cultures raise the possibility of uncommon or rare pathogens, including-but not limited to-Bartonella species, Coxiella burnetii, and Brucella species (2). The first question we would like to address is whether the patient was exposed to animals, such as domestic cats, or dairy activity (even though such zoonoses are very rare in Japan) (3, 4)? Furthermore, anti-phospholipid antibody syndrome may mimic endocarditis (2). Although this patient's antinuclear antibody (ANA) test was negative (1), not only systemic lu-